Pharmaboom Articles

Eli Lilly and Company
(NYSE: LLY) announced that the U.S. Food and Drug Administration
(FDA) has approved Cialis(R) (tadalafil)(1) for once daily use (2.5 mg and
5 mg), an oral medication taken once per day to treat erectile dysfunction
(ED). When Cialis for Read the rest of this entry »

A study published in JAMA reports that adults are
more likely to have posttraumatic stress disorder symptoms if they have
been abused as a child and have variations of a gene that is related to
stress response. The investigation was conducted by Rebekah G. Bradley,
Ph.D. (Emory University School of Medicine, Atlanta) and colleagues.
Providing background information, the authors write: "Posttraumatic
stress Read the rest of this entry »

Inhibiting the proton currents in basophils, a rare type of white blood cell, can stop the release of histamine and could provide a new target for allergy and asthma drugs according to a new study by researchers at Rush University Medical Center in Chicago and the Johns Hopkins Asthma and Allergy Center in Baltimore. The Read the rest of this entry »

Cytos Biotechnology Ltd (SWX:CYTN) announced
results from two randomized, double-blind, placebo-controlled,
multicentre phase II studies
with CYT003-QbG10 monotherapy for the treatment of house dust mite and cat
allergy, and with
CYT005-AllQbG10 combination therapy for the treatment of house dust mite
allergy. The studies were
conducted in order to determine whether QbG10 acts through an
allergen-independent or allergendependent
mechanism Read the rest of this entry »

UC Irvine researchers have identified the brain mechanism that switches off traumatic feelings associated with bad memories, a finding that could lead to the development of drugs to treat panic disorders.
Scientists from UCI and the University of Muenster in Germany found that a small brain protein called neuropeptide S is involved in erasing traumatic responses to adverse memories by working on a tiny group of Read the rest of this entry »